Moxbro CV DS (30 ml) Syrup

Moxbro CV DS (30 ml) is a Fixed-Dose Combination (FDC) Drug Brand being manufactured and marketed by DWD Pharmaceuticals Ltd.. This medicine is combination of more than one active ingredient or substance within a single pharmaceutical form type. The main active ingredients or salts in this drug are Amoxycillin, Clavulanic Acid. This drug comes in the form of Syrup. The general packing available for this medicine consists of 30 ml and is priced at Rs 79 (arround $1.106 US Dollar)
Generic (Salt) Combination :(Amoxycillin+ Clavulanic Acid)
Pharma Company :DWD Pharmaceuticals Ltd.
Brand Label :Moxbro CV DS (30 ml)
Preparation Type :Syrup
Single Dose :5 ml
Composition (Fixed-Dose Combination) :
  • Amoxycillin-400 mg
  • Clavulanic Acid-57 mg
Pack Size/Qty/Vol :30 ml
Price Unit :Rs 13.17 INR (arround $0.18438 US Dollar)
Price Pack :Rs 79 INR (arround $1.106 US Dollar)

Drug details for Moxbro CV DS (30 ml)

Usage: Why is this medication prescribed?

The main active ingredients or salts in Moxbro CV DS (30 ml) are :

  • Amoxycillin-400 mg
  • Clavulanic Acid-57 mg

Amoxycillin
Indication (Prescribed for or used as): Respiratory, genito-urinary, skin and soft tissue, ENT infections due to susceptible strains of Gram negative organisms like H.influenzae, E-coli, P.mirabilis and N. gonorrhoea. Gram positive organisms like streptococci (including streptococcus faecalis) D. pneumoniae and non-penicillase producing staphylococci.

For more details on Amoxycillin, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Amoxycillin..

Clavulanic Acid
Indication (Prescribed for or used as):

For more details on Clavulanic Acid, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Clavulanic Acid..

Moxbro CV DS (30 ml) Drug Brands Substitutes with similar Fixed-Dose Combination (FDC) :

There are 18 Fixed-Dose Combination (FDC) Drug Brands listed here as Substitutes for Moxbro CV DS (30 ml), which have same Fixed-Dose Combination of active substances or ingredients (i.e. Amoxycillin-400 mg Clavulanic Acid-57 mg).
Please note that one can request a doctor or pharmacist to substitute a FDC Brand Version of the prescribed FDC drug brand, if any. Fixed-Dose Combination Drugs are being increasingly used due to the benefit of the combined effects of active ingredients given together. However, it is necessary to investigate the possible benefits in the clinical situation against possible disadvantages for each fixed combination drug and for each dose of the fixed combination drug. Potential advantages of fixed combination drugs may also include the counteracting by one ingredient of an adverse reaction produced by another one, and simplification of therapy, leading to improved compliance.

BrandPrice (Rs.)BrandPrice (Rs.)
AB CV Forte DS (30 ml) 95Athoclav DS 109.9
Bilclav (30 ml) 105Bio-Clav (30 ml) 130
Clavage (400+57) 99Clavilite DS (400+57 mg) 98
Enhancin DS Susp. (30 ml) 95.8Esmox CV (400+57 mg) 110
Flemiclav Forte (30 ml) 80Mega CV Forte (30 ml) 85
Mega CV Forte DT (400+57) 86Moxicross CV Forte 110
Pamclav DS (30 ml) 75Ronclav (400+57) 99.9
Viktoclav DS 122Vinclav DS (30 ml) 119
Xoclave Duo (30 ml) 79.99Zoxil CV (400+57) 97.25

Moxbro CV DS (30 ml) Syrup

Moxbro CV DS (30 ml) is a Fixed-Dose Combination (FDC) Drug Brand being manufactured and marketed by DWD Pharmaceuticals Ltd.. This medicine is combination of more than one active ingredient or substance within a single pharmaceutical form type. The main active ingredients or salts in this drug are Clavulanic Acid, Amoxycillin. This drug comes in the form of Syrup. The general packing available for this medicine consists of 30 ml and is priced at Rs 79 (arround $1.106 US Dollar)
Generic (Salt) Combination :(Clavulanic Acid+ Amoxycillin)
Pharma Company :DWD Pharmaceuticals Ltd.
Brand Label :Moxbro CV DS (30 ml)
Preparation Type :Syrup
Single Dose :5 ml
Composition (Fixed-Dose Combination) :
  • Clavulanic Acid-57 mg
  • Amoxycillin-400 mg
Pack Size/Qty/Vol :30 ml
Price Unit :Rs 13.17 INR (arround $0.18438 US Dollar)
Price Pack :Rs 79 INR (arround $1.106 US Dollar)

Drug details for Moxbro CV DS (30 ml)

Usage: Why is this medication prescribed?

The main active ingredients or salts in Moxbro CV DS (30 ml) are :

  • Clavulanic Acid-57 mg
  • Amoxycillin-400 mg

Clavulanic Acid
Indication (Prescribed for or used as):

For more details on Clavulanic Acid, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Clavulanic Acid..

Amoxycillin
Indication (Prescribed for or used as): Respiratory, genito-urinary, skin and soft tissue, ENT infections due to susceptible strains of Gram negative organisms like H.influenzae, E-coli, P.mirabilis and N. gonorrhoea. Gram positive organisms like streptococci (including streptococcus faecalis) D. pneumoniae and non-penicillase producing staphylococci.

For more details on Amoxycillin, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Amoxycillin..

Moxbro CV DS (30 ml) Drug Brands Substitutes with similar Fixed-Dose Combination (FDC) :

There are 0 Fixed-Dose Combination (FDC) Drug Brands listed here as Substitutes for Moxbro CV DS (30 ml), which have same Fixed-Dose Combination of active substances or ingredients (i.e. Clavulanic Acid-57 mg Amoxycillin-400 mg).
Please note that one can request a doctor or pharmacist to substitute a FDC Brand Version of the prescribed FDC drug brand, if any. Fixed-Dose Combination Drugs are being increasingly used due to the benefit of the combined effects of active ingredients given together. However, it is necessary to investigate the possible benefits in the clinical situation against possible disadvantages for each fixed combination drug and for each dose of the fixed combination drug. Potential advantages of fixed combination drugs may also include the counteracting by one ingredient of an adverse reaction produced by another one, and simplification of therapy, leading to improved compliance.

BrandPrice (Rs.)BrandPrice (Rs.)

Search Drug Brands alphabetically